Mr. Sachdev joined Vertex in 2007. As Vertex’s Executive Vice President, Policy, Access and Value, Mr. Sachdev manages our global market access, health economics and outcomes research efforts for our approved and pipeline medicines.
He also oversees our government affairs and public policy activities, as well as the company’s patient advocacy programs. In 2010, he established our first international commercial operations.
Prior to Vertex, Mr. Sachdev served as Executive Vice President, Health, at the Biotechnology Industry Organization (BIO) and was Deputy Commissioner for Policy at the U.S. Food and Drug Administration (FDA) where he also held several other senior appointments beginning in 2002. Earlier in his career, Mr. Sachdev served as Majority Counsel to the Committee on Energy and Commerce in the U.S. House of Representatives and practiced law at the American Chemistry Council and subsequently at the law firm of Ropes & Gray.
Mr. Sachdev received a B.S from Carnegie Mellon University and a J.D. from Emory University School of Law.